Literature DB >> 25720016

Ultrasound-Based Characterization of Prostate Cancer Using Joint Independent Component Analysis.

Farhad Imani1, Mahdi Ramezani2, Saman Nouranian2, Eli Gibson3, Amir Khojaste4, Mena Gaed3, Madeleine Moussa5, Jose A Gomez5, Cesare Romagnoli5, Michael Leveridge6, Silvia Chang7, Aaron Fenster3, D Robert Siemens6, Aaron D Ward8, Parvin Mousavi4, Purang Abolmaesumi2.   

Abstract

OBJECTIVE: This paper presents the results of a new approach for selection of RF time series features based on joint independent component analysis for in vivo characterization of prostate cancer.
METHODS: We project three sets of RF time series features extracted from the spectrum, fractal dimension, and the wavelet transform of the ultrasound RF data on a space spanned by five joint independent components. Then, we demonstrate that the obtained mixing coefficients from a group of patients can be used to train a classifier, which can be applied to characterize cancerous regions of a test patient.
RESULTS: In a leave-one-patient-out cross validation, an area under receiver operating characteristic curve of 0.93 and classification accuracy of 84% are achieved.
CONCLUSION: Ultrasound RF time series can be used to accurately characterize prostate cancer, in vivo without the need for exhaustive search in the feature space. SIGNIFICANCE: We use joint independent component analysis for systematic fusion of multiple sets of RF time series features, within a machine learning framework, to characterize PCa in an in vivo study.

Entities:  

Mesh:

Year:  2015        PMID: 25720016     DOI: 10.1109/TBME.2015.2404300

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  6 in total

1.  Detection and grading of prostate cancer using temporal enhanced ultrasound: combining deep neural networks and tissue mimicking simulations.

Authors:  Shekoofeh Azizi; Sharareh Bayat; Pingkun Yan; Amir Tahmasebi; Guy Nir; Jin Tae Kwak; Sheng Xu; Storey Wilson; Kenneth A Iczkowski; M Scott Lucia; Larry Goldenberg; Septimiu E Salcudean; Peter A Pinto; Bradford Wood; Purang Abolmaesumi; Parvin Mousavi
Journal:  Int J Comput Assist Radiol Surg       Date:  2017-06-20       Impact factor: 2.924

2.  Detection of prostate cancer using temporal sequences of ultrasound data: a large clinical feasibility study.

Authors:  Shekoofeh Azizi; Farhad Imani; Sahar Ghavidel; Amir Tahmasebi; Jin Tae Kwak; Sheng Xu; Baris Turkbey; Peter Choyke; Peter Pinto; Bradford Wood; Parvin Mousavi; Purang Abolmaesumi
Journal:  Int J Comput Assist Radiol Surg       Date:  2016-04-08       Impact factor: 2.924

3.  Transfer learning from RF to B-mode temporal enhanced ultrasound features for prostate cancer detection.

Authors:  Shekoofeh Azizi; Parvin Mousavi; Pingkun Yan; Amir Tahmasebi; Jin Tae Kwak; Sheng Xu; Baris Turkbey; Peter Choyke; Peter Pinto; Bradford Wood; Purang Abolmaesumi
Journal:  Int J Comput Assist Radiol Surg       Date:  2017-03-27       Impact factor: 2.924

4.  Deep Recurrent Neural Networks for Prostate Cancer Detection: Analysis of Temporal Enhanced Ultrasound.

Authors:  Shekoofeh Azizi; Sharareh Bayat; Pingkun Yan; Amir Tahmasebi; Jin Tae Kwak; Sheng Xu; Baris Turkbey; Peter Choyke; Peter Pinto; Bradford Wood; Parvin Mousavi; Purang Abolmaesumi
Journal:  IEEE Trans Med Imaging       Date:  2018-06-25       Impact factor: 10.048

5.  Improving detection of prostate cancer foci via information fusion of MRI and temporal enhanced ultrasound.

Authors:  Alireza Sedghi; Alireza Mehrtash; Amoon Jamzad; Amel Amalou; William M Wells; Tina Kapur; Jin Tae Kwak; Baris Turkbey; Peter Choyke; Peter Pinto; Bradford Wood; Sheng Xu; Purang Abolmaesumi; Parvin Mousavi
Journal:  Int J Comput Assist Radiol Surg       Date:  2020-05-05       Impact factor: 2.924

6.  Multi-modal data fusion using source separation: Two effective models based on ICA and IVA and their properties.

Authors:  Tülay Adali; Yuri Levin-Schwartz; Vince D Calhoun
Journal:  Proc IEEE Inst Electr Electron Eng       Date:  2015-09-01       Impact factor: 10.961

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.